Suchergebnisse - "Moore, Donald C."

PubPharm (92)

1

Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia

enthalten in: Leukemia & lymphoma | 2024

von Fleck, C. | Karabinos, A. | Cook, A. | +2

2

Successful Ferric Carboxymaltose Desensitization in a Patient With Prior Reactions to Intravenous Iron Therapies

enthalten in: American journal of therapeutics | 2024

von Elmes, J. | Moore, D. | Pineda-Roman, M.

3

Pharmacist perspectives on emerging T cell-engaging bispecific therapies in cancer therapeutics

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2024

von Moore, D. | Digiantonio, N. | Oxencis, C. | +1

4

PD-1/PD-L1 inhibitor-induced immune thrombocytopenia : A pharmacovigilance study and systematic review

enthalten in: International immunopharmacology | 2024

von Moore, D. | Elmes, J. | Arnall, J. | +2

5

Avatrombopag for the Treatment of Immune Thrombocytopenia and Periprocedural Thrombocytopenia Associated With Chronic Liver Disease

enthalten in: Journal of pharmacy practice | 2024

von Tran, T. | Downing, L. | Elmes, J. | +2

6

Alpelisib-Induced Diabetic Ketoacidosis : A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and Review of the Literature

enthalten in: Clinical breast cancer | 2024

von Ziegengeist, J. | Elmes, J. | Strassels, S. | +2

7

Professional and career development needs of clinical pharmacists in settings outside academia

enthalten in: Journal of the American College of Clinical Pharmacy | 2024

von Hayes, S. | Moore, D. | Droney, M. | +6

8

Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies : a pharmacovigilance analysis

enthalten in: International journal of clinical pharmacy | 2023

von Moore, D. | Elmes, J. | Arnall, J. | +2

9

Use of patient-reported outcome measures for oncology drugs receiving accelerated approval

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2023

von Moore, D. | Elmes, J. | Strassels, S. | +1

10

Use of patient-reported outcome measures for oncology drugs receiving accelerated approval

enthalten in: Supportive care in cancer | 2023

von Moore, D. | Elmes, J. | Strassels, S. | +1

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]